NBY News and Press, NovaBay Pharmaceuticals Inc. From 07/29/19

Gainers:  NovaBay Pharmaceuticals (NYSEMKT: NBY ) +34% . Medley Management (NYSE: MDLY ) +33% . Pieris Pharmaceuticals (NASDAQ: PIRS ) +24% . Daxor (NYSEMKT: DXR ) +18% . Oasmia Pharmaceutical AB (NASDAQ: OASM ) +17% . Acasti Pharma (NASDAQ: ACST ) +15% . Mylan N.V. (NASDAQ: MYL...

Medley Management (NYSE: MDLY ) +35%  as Sierra, Medley Capital, Medley Management amend merger deals . More news on: Medley Management Inc., Sintx Technologies, Inc., NovaBay Pharmaceuticals, Inc., Stocks on the move, Read more ...

NovaBay (NYSEMKT: NBY ): Q2 revenue of $1.8M (-39.0% Y/Y) beats by $0.27M . The company will report its 2Q19 results on 8th August, 2019. Press Release More news on: NovaBay Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, ,

Company to hold second quarter 2019 conference call on August 8 NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing Avenova ® for the domestic eye care market, reports net sales of $1.8 million for the three months...

NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing Avenova ® for the domestic eye care market, announces that President and CEO Justin Hall has issued the following letter to stockholders: To My Fellow Stockholders: ...

Infrastructure and Energy Alternatives (NASDAQ: IEA ) +24% . on announcing two new wind energy project awards valued at ~$150M. More news on: Infrastructure and Energy Alternatives, Inc., NeoPhotonics Corporation, Pareteum Corporation, Stocks on the move, Read more ...

Infrastructure and Energy Alternatives (NASDAQ: IEA ) +24% . on announcing two new wind energy project awards valued at ~$150M. More news on: Infrastructure and Energy Alternatives, Inc., NeoPhotonics Corporation, Pareteum Corporation, Stocks on the move, Read more ...

NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing Avenova ® for the domestic eye care market, announces that the New York Stock Exchange (NYSE) has accepted the Company’s plan to regain compliance with the NYSE...

NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing Avenova ® for the domestic eye care market, announces that the New York Stock Exchange (NYSE) has accepted the Company’s plan to regain compliance with the NYSE...

NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing Avenova ® for the domestic eye care market, announces the closing of a private placement of common stock and warrants with accredited investors, raising gross procee...